Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2Novartis Pharmaceuticals Australia Pty Limited

02 10Novartis Pharmaceuticals Corporation

03 1Novartis South Africa (Pty) Ltd

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

OFATUMUMAB

Brand Name : ARZERRA

Dosage Form : INJECTABLE; INJECTION

Dosage Strength : 100MG/5ML

Packaging :

Approval Date :

Application Number : 125326

Regulatory Info :

Registration Country : USA

blank

02

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

OFATUMUMAB

Brand Name : KESIMPTA

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 20MG/0.4ML

Packaging :

Approval Date :

Application Number : 125326

Regulatory Info :

Registration Country : USA

blank

03

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Ofatumumab

Brand Name : Kesimpta

Dosage Form : Solution For Injection

Dosage Strength : 20mg

Packaging :

Approval Date : 26/03/2021

Application Number : 20200110000103

Regulatory Info : Approved

Registration Country : Sweden

blank

04

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Ofatumumab

Brand Name : Kesimpta

Dosage Form : Solution For Injection

Dosage Strength : 20mg

Packaging :

Approval Date : 26/03/2021

Application Number : 20200110000097

Regulatory Info : Approved

Registration Country : Sweden

blank

05

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Ofatumumab

Brand Name : Arzerra

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 100mg

Packaging :

Approval Date : 19/04/2010

Application Number : 20090310000023

Regulatory Info : Deregistered

Registration Country : Sweden

blank

06

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Ofatumumab

Brand Name : Arzerra

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 1000mg

Packaging :

Approval Date : 21/02/2011

Application Number : 20110319000036

Regulatory Info : Deregistered

Registration Country : Sweden

blank

07

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Ofatumumabum

Brand Name : Kesimpta

Dosage Form : Solution For Injection

Dosage Strength : 20mg/0.4ml

Packaging :

Approval Date : 01/02/2021

Application Number : 67757

Regulatory Info : Allowed

Registration Country : Switzerland

blank

08

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Ofatumumabum

Brand Name : Kesimpta

Dosage Form : Solution For Injection

Dosage Strength : 20mg/0.4ml

Packaging :

Approval Date : 01/02/2021

Application Number : 67758

Regulatory Info : Allowed

Registration Country : Switzerland

blank

09

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

OFATUMUMAB

Brand Name : KESIMPTA

Dosage Form : SOLUTION

Dosage Strength : 20MG/0.4ML

Packaging :

Approval Date :

Application Number : 2511355

Regulatory Info : Schedule D

Registration Country : Canada

blank

10

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Ofatumumab

Brand Name : Kesimpta

Dosage Form : Injectable Solution In Pre-Filled Pen

Dosage Strength : 20MG

Packaging :

Approval Date : 2021-05-10

Application Number : 121532003

Regulatory Info : Authorized

Registration Country : Spain

blank

11

Novartis South Africa (Pty) Ltd

Country
Aus. Peptide Conference
Not Confirmed
arrow

Novartis South Africa (Pty) Ltd

Country
arrow
Aus. Peptide Conference
Not Confirmed

Ofatumumab

Brand Name : Bonspri

Dosage Form : INJ

Dosage Strength : 20mg

Packaging : 1X1mg

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

blank

12

Novartis Pharmaceuticals Australia ...

Country
Aus. Peptide Conference
Not Confirmed
arrow

Novartis Pharmaceuticals Australia ...

Country
arrow
Aus. Peptide Conference
Not Confirmed

Ofatumumab

Brand Name : Kesimpta

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

13

Novartis Pharmaceuticals Australia ...

Country
Aus. Peptide Conference
Not Confirmed
arrow

Novartis Pharmaceuticals Australia ...

Country
arrow
Aus. Peptide Conference
Not Confirmed

Ofatumumab

Brand Name : Kesimpta

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank